Long-term safety and effectiveness of etanercept in pediatric psoriasis patients: Results from a prospective observational cohort study

被引：0

作者：

Gu, Yun ^{[1
]}

Brinkley, Emma ^{[2
]}

Sobel, Rachel E. ^{[3
]}

Gelfand, Joel M. ^{[4
]}

Seyger, Marieke ^{[5
]}

Szalai, Zsuzsanna ^{[6
]}

Lacour, Jean-Philippe ^{[7
]}

Stahle, Mona ^{[8
]}

机构：

[1] Pfizer Inc, Collegeville, PA USA

[2] IQVIA, Durham, NC USA

[3] United BioSource Corp, Blue Bell, PA USA

[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA

[5] Univ Med Ctr St, Nijmegen, Netherlands

[6] Heim Pal Childrens Hosp, Budapest, Hungary

[7] Hop Archet II, Nice, France

[8] Karolinska Inst, Stockholm, Sweden

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2020年 / 29卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

2477

引用

页码：17 / 18

页数：2

共 50 条

[21] Long-term Safety and Dosing of OnabotulinumtoxinA: A Prospective, Observational Study
Wein, Theodore
Jog, Mandar
Bhogal, Meetu
Dhani, Sonja
Miller, Robert
Ismail, Farooq
Beauchamp, Richard
Trentin, Grace
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 2019, 46 (06) : 742 - 752
[22] Short- and long-term safety profiles of etanercept in patients with psoriasis: An integrated analysis
Pariser, David
Yang, Yu-Ching
Leonardi, Craig
Stevens, Seth
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2008, 58 (02) : AB121 - AB121
[23] Safety and Effectiveness Profile of Raloxifene in Long-term Prospective Observational Study; Interim Analysis.
Miyauchi, A.
Hamaya, E.
Tsuzuki, D.
Kishimoto, H.
Yoshiki, F.
Okada, H.
Kobayashi, H.
Yokoyama, S.
Tanaka, A.
Tara, H.
JOURNAL OF BONE AND MINERAL RESEARCH, 2008, 23 : S470 - S470
[24] Long-term safety and efficacy of 50 mg of etanercept twice weekly in patients with psoriasis
Tyring, Stephen
Gordon, Kenneth B.
Poulin, Yves
Langley, Richard G.
Gottlieb, Alice B.
Dunn, Meleana
Jahreis, Angelika
ARCHIVES OF DERMATOLOGY, 2007, 143 (06) : 719 - 726
[25] Intermediate to long-term efficacy and safety of etanercept: report from the psoriasis registry Austria
Inzinger, M.
Roschatt, I.
Weger, W.
Salmhofer, W.
Wolf, P.
JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S60 - S60
[26] Long-term safety and tolerability of apremilast in patients with moderate to severe psoriasis: Results from the LIBERATE study
Crowley, Jeffrey
Langley, Richard
Zhang, Zuoshun
Goncalves, Joana
Paris, Maria
Reich, Kristian
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB259 - AB259
[27] Long-term safety and efficacy of etanercept in children and adolescents with plaque psoriasis
Paller, Amy S.
Siegfried, Elaine C.
Pariser, David M.
Rice, Kara Creamer
Trivedi, Mona
Iles, Jan
Collier, David H.
Kricorian, Greg
Langley, Richard G.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (02) : 280 - 287
[28] Determinants of long-term drug survival of etanercept in patients with plaque psoriasis: a daily-practice cohort study
Van den Reek, J.
de Jong, E.
van de Kerkhof, P.
Seyger, M.
van Lumig, P.
Kievit, W.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2013, 27 : 1 - 2
[29] Long-term effectiveness and safety of infliximab, golimumab and ustekinumab in patients with psoriatic arthritis from a Canadian prospective observational registry
Rahman, Proton
Arendse, Regan
Khraishi, Majed
Sholter, Dalton
Sheriff, Maqbool
Rampakakis, Emmanouil
Lehman, Allen J.
Nantel, Francois
BMJ OPEN, 2020, 10 (08):
[30] LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY
Kiltz, U.
Sfikakis, P.
Gullick, N.
Katsimpri, P.
Kotrotsios, A.
Brandt-Juergens, J.
Lespessailles, E.
Maiden, N.
Gaffney, K.
Peterlik, D.
Schulz, B.
Pournara, E.
Jagiello, P.
ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 846 - 847

← 1 2 3 4 5 →